Seven Years at 700: The Marathon Runner Whose Sky-High Cholesterol Left His Arteries Spotless
A lean, athletic man in his 30s adopted a ketogenic diet to control ulcerative colitis and watched his LDL cholesterol climb sixfold, from 95 to 574 mg/dL, with total cholesterol peaking above 700 mg/dL. He held those levels for close to seven years while taking essentially no lipid-lowering drugs. Two separate CT angiograms, plus AI-guided plaque quantification, found zero coronary plaque and no stenosis, placing him in the lowest percentile for atherosclerosis. The authors present him as an extreme, exhaustively documented example of the lean mass hyper-responder phenotype and argue that LDL number alone, stripped of metabolic context, is a poor predictor of arterial disease in this specific group. The paper does not claim high LDL is safe for everyone.
The textbook says the arithmetic is simple. Push LDL cholesterol high enough, for long enough, and plaque accumulates in the coronary arteries. The man at the center of this case report has spent nearly seven years testing that arithmetic on his own body, and the plaque has not arrived.
He is described as a lean, competitive endurance athlete with body fat under 12 percent and a resting heart rate in the 40s. In his early 20s he adopted a strict ketogenic diet, roughly 80 percent fat and 2 percent carbohydrate, to manage ulcerative colitis that ordinary drugs had failed to control. The diet worked for his gut. It also rewired his lipid panel in dramatic fashion. His LDL cholesterol rose from a pre-diet 95 mg/dL to a measured peak of 574, his total cholesterol reached 705, and his apolipoprotein B, the count of atherogenic particles, more than quadrupled to 335 mg/dL.
Under conventional risk models these are alarming figures. Yet the rest of his profile broke the usual pattern. His HDL cholesterol rose to 124, his triglycerides fell to 34, his fasting insulin stayed rock bottom, and his inflammatory marker dropped. This triad of very high LDL, very high HDL, and low triglycerides in a lean, insulin-sensitive person defines what researchers now call the lean mass hyper-responder.
The decisive data came from imaging. On CT angiography in 2021 and again in 2026, and on AI-guided quantification by a clinically validated platform, his coronary arteries showed a calcium score of zero, no stenosis, and a total plaque volume of 0 cubic millimeters. He sits in the lowest percentile for plaque despite carrying possibly the highest sustained LDL burden ever documented on serial cardiac imaging.
The authors are careful. One patient cannot overturn decades of cardiology, and this individual also carries elevated lipoprotein(a), a genetic risk factor. But the case dovetails with a larger cohort of 100 similar individuals in which baseline plaque, not LDL or apoB, predicted future plaque. The uncomfortable implication is that the same cholesterol number may carry very different meaning depending on who is carrying it.
Actionable Insights
The honest headline first: this is one person, and nothing here means high LDL is harmless for you. What the case offers is a set of levers, and it lets us size them.
The clearest practical lesson is about metabolic context. The traits that travel with this man’s apparent resistance to plaque are low body fat, high physical activity, low triglycerides, and low fasting insulin. Those are the same markers that predict good cardiovascular outcomes across the general population, and they are largely within your control.
The second lesson is how strongly diet moves LDL in lean, low-carb responders. When this patient added about 100 grams of carbohydrate a day for just 16 days, his LDL fell 71 percent. To put that magnitude in plain terms, that single dietary change lowered his cholesterol more than high-dose statin therapy did. For comparison, his statin cut LDL 31 percent, bempedoic acid 28 percent, and ezetimibe 56 percent. So the effect size of a food change here rivaled or beat prescription drugs.
The takeaway is not to eat Oreos. It is that if you follow a low-carb diet and see LDL spike, that spike is often reversible through diet, and the size of the reversal can be large. Track particle count (apoB), image plaque directly if warranted, and treat the whole metabolic picture rather than a single number. [Confidence: Medium]
